Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Blast Crisis × carfilzomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 179 Recurrence 32 Neoplasms, Plasma Cell 16 Lymphoma 11 Waldenstrom Macroglobulinemia 6 Neoplasms 6 Lymphoma, Mantle-Cell 6 Lymphoma, Non-Hodgkin 5 Lymphoma, Large B-Cell, Diffuse 5 Smoldering Multiple Myeloma 4 Leukemia 4 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, B-Cell, Marginal Zone 3 Hodgkin Disease 3 Hematologic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Leukemia, Plasma Cell 2 Leukemia, Myeloid, Acute 2 Kidney Neoplasms 2 Disease 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Salivary Gland Adenoma, Pleomorphic 1

Interventions

Cyclophosphamide 64 Peripheral Blood Stem Cell Transplantation 58 fludarabine phosphate 55 Busulfan 44 Tacrolimus 39 Methotrexate 38 Cytarabine 37 Filgrastim 34 Mycophenolic Acid 33 Cyclosporine 33 Antilymphocyte Serum 32 Whole-Body Irradiation 28 Radiotherapy 25 Methylprednisolone 22 Imatinib Mesylate 22 Etoposide 22 Melphalan 18 Cord Blood Stem Cell Transplantation 18 Flow Cytometry 14 Thiotepa 12 Dasatinib 12 Therapeutics 11 sargramostim 10 merphos 10 fludarabine 10 Sirolimus 10 Granulocyte Colony-Stimulating Factor 10 nilotinib 9 Prednisone 9 Decitabine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204164 2016-05-06

TG02-101

Tragara Pharmaceuticals, Inc.

Phase 1 Completed

Blast Crisis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡